pSDMA25
(Plasmid
#67940)
-
Purpose(Empty Backbone) Complementation in Cryptococcus neoformans. Targets DNA constructs to a Safe Haven Site, a small gene-free region. Contains nourseothricin resistance marker (NAT)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 67940 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBluescript II -SK
-
Backbone manufacturerStratagene
-
Modifications to backboneAdded Safe Haven gene free region (intergenic region between H99 ORFs CNAG_00777 and CNAG_00778) and NAT resistance marker and removed F1 origin
-
Vector typeCryptococcal complementation vector
- Promoter ACT1 for Cryptococcal marker
-
Selectable markersNourseothricin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Cloning Information
- Cloning method Restriction Enzyme
- 5′ sequencing primer M13F
- 3′ sequencing primer M13 Reverse (Common Sequencing Primers)
Resource Information
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Contains the safe haven site sequence in the backbone of pBluescript II SK- to enable integration into the C. neoformans genome via homologous recombination, in addition to a linker sequence containing multiple rare-cutting restriction enzyme cut sites to facilitate linearization prior to biolistic transformation. Importantly, as the safe haven and marker fragments were inserted into the pBluescript II SK- backbone in place of the f1 origin of replication, each plasmid still retains the original multicloning site and blue/white screening capabilities. Linearization of the safe haven constructs is made possible by the inclusion of a linker containing cut sites for three rare cutting restriction enzymes—BaeI, AscI and PacI. To use the vectors, the gene of interest is subcloned into the standard pBluescript II SK- multicloning site.
If possible BaeI should be used, as it integrates into the safe haven site approximately 60% of the time, while AscI and PacI only 10-16%.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pSDMA25 was a gift from James Fraser (Addgene plasmid # 67940 ; http://n2t.net/addgene:67940 ; RRID:Addgene_67940) -
For your References section:
A genomic safe haven for mutant complementation in Cryptococcus neoformans. Arras SD, Chitty JL, Blake KL, Schulz BL, Fraser JA. PLoS One. 2015 Apr 9;10(4):e0122916. doi: 10.1371/journal.pone.0122916. eCollection 2015. PONE-D-15-02673 [pii] PubMed 25856300